ES2177290T3 - Sistema de administracion transdermica con hormonas e inhibidores de cristalizacion. - Google Patents

Sistema de administracion transdermica con hormonas e inhibidores de cristalizacion.

Info

Publication number
ES2177290T3
ES2177290T3 ES99927904T ES99927904T ES2177290T3 ES 2177290 T3 ES2177290 T3 ES 2177290T3 ES 99927904 T ES99927904 T ES 99927904T ES 99927904 T ES99927904 T ES 99927904T ES 2177290 T3 ES2177290 T3 ES 2177290T3
Authority
ES
Spain
Prior art keywords
transdermal administration
administration system
hormones
crystallization inhibitors
estradiol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99927904T
Other languages
English (en)
Inventor
Robert Peter Klein
Reinhold Meconi
Walter Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2177290T3 publication Critical patent/ES2177290T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/932—Specified use of nanostructure for electronic or optoelectronic application
    • Y10S977/939—Electron emitter, e.g. spindt emitter tip coated with nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Sistema de administración transdérmica en forma de apósito para la transferencia controlada de estradiol en combinación con acetato de noretisterona, constituido por una capa superior, un reservorio sobresaturado de principios activos unido a ella, que contiene estradiol y acetato de noretisterona, el cual está fabricado a base de adhesivos de contacto de poliacrilato e inhibidores de cristalización, y una capa protectora amovible, caracterizado por ser el inhibidor de cristalización un polímero que contiene grupos amino.
ES99927904T 1998-06-25 1999-06-08 Sistema de administracion transdermica con hormonas e inhibidores de cristalizacion. Expired - Lifetime ES2177290T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19828273A DE19828273B4 (de) 1998-06-25 1998-06-25 Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren

Publications (1)

Publication Number Publication Date
ES2177290T3 true ES2177290T3 (es) 2002-12-01

Family

ID=7871950

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99927904T Expired - Lifetime ES2177290T3 (es) 1998-06-25 1999-06-08 Sistema de administracion transdermica con hormonas e inhibidores de cristalizacion.

Country Status (23)

Country Link
US (1) US6899894B1 (es)
EP (1) EP1089719B1 (es)
JP (1) JP2002518430A (es)
KR (1) KR100550888B1 (es)
CN (1) CN1148172C (es)
AR (1) AR019715A1 (es)
AT (1) ATE215819T1 (es)
AU (1) AU768755B2 (es)
BR (1) BR9912210A (es)
CA (1) CA2335582C (es)
CZ (1) CZ300707B6 (es)
DE (2) DE19828273B4 (es)
DK (1) DK1089719T3 (es)
ES (1) ES2177290T3 (es)
HU (1) HUP0102498A3 (es)
IL (2) IL140434A0 (es)
NZ (1) NZ509015A (es)
PL (1) PL193080B1 (es)
PT (1) PT1089719E (es)
TR (1) TR200003839T2 (es)
TW (1) TW533084B (es)
WO (1) WO1999066901A2 (es)
ZA (1) ZA200007751B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
DE10025971B4 (de) * 2000-05-25 2004-09-02 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System in Plasterform mit verminderter Tendenz zur Wirkstoffkristallisation und seine Verwendung
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US6750291B2 (en) * 2002-04-12 2004-06-15 Pacific Corporation Film-forming agent for drug delivery and preparation for percutaneous administration containing the same
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
US8246980B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
US8211462B2 (en) * 2002-07-30 2012-07-03 Ucb Pharma Gmbh Hot-melt TTS for administering rotigotine
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
US20040086551A1 (en) * 2002-10-30 2004-05-06 Miller Kenneth J. Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
ES2239196T3 (es) * 2002-12-02 2005-09-16 Schwarz Pharma Ag Suministro iontoforetico de rotigotina para el tratamiento de la enfermedad de parkinson.
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
US20080286348A1 (en) * 2007-05-16 2008-11-20 Todhunter John A Secured transdermal delivery system
US9155725B2 (en) * 2008-02-27 2015-10-13 Hisamitsu Pharmaceutical Co., Inc. Adhesive skin patch and packaged product
JP6054013B2 (ja) * 2008-02-27 2016-12-27 久光製薬株式会社 貼付製剤
JP5547065B2 (ja) 2008-05-15 2014-07-09 久光製薬株式会社 パロノセトロンを含有する経皮吸収製剤
US8366600B2 (en) * 2008-06-19 2013-02-05 Nupathe Inc. Polyamine enhanced formulations for triptan compound iontophoresis
CN103933018A (zh) * 2013-01-18 2014-07-23 江苏康倍得药业有限公司 一种透皮给药系统
EP3395336A1 (en) * 2017-04-28 2018-10-31 Nitto Denko Corporation Transdermal absorption preparation

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0745400B2 (ja) * 1986-03-29 1995-05-17 日東電工株式会社 外用医薬製剤
US4954343A (en) * 1986-03-29 1990-09-04 Nitto Electric Industrial Co., Ltd. Dermal pharmaceutical preparations
DE3743946A1 (de) 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von nitroglycerin an die haut, verfahren zu ihrer herstellung sowie ihre verwendung
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
JP2857882B2 (ja) * 1988-11-02 1999-02-17 富山化学工業株式会社 ピロキシカムのプラスター剤
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
DE3939376C1 (es) * 1989-11-29 1991-05-08 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg, 5450 Neuwied, De
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
JPH04261119A (ja) * 1991-02-13 1992-09-17 Lintec Corp 経皮吸収型貼付剤
CA2077369A1 (en) 1991-09-09 1993-03-10 Hitoshi Akemi Acrylic gel material and gel-based medical preparation for percutaneous absorption employing the same
US5676968A (en) * 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
US5286810A (en) * 1992-08-07 1994-02-15 Srchem Incorporated Salt of polymer from maleic acid, polyamind and ammonia
DE4230588C1 (de) * 1992-09-12 1993-10-07 Lohmann Therapie Syst Lts Dexpanthenol-haltiges Pflaster zur transdermalen Applikation von Steroidhormonen und Verfahren zu seiner Herstellung
DE4238223C1 (de) * 1992-11-12 1994-05-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
DE59405277D1 (de) * 1993-04-20 1998-03-26 Hexal Ag Wirkstoffplaster
DE4336557C2 (de) 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4333595A1 (de) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
WO1995030409A1 (en) 1994-05-05 1995-11-16 Merck Frosst Canada Inc. Topical polymeric drug delivery system
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
DE19548332A1 (de) * 1995-12-22 1997-07-10 Rotta Res Bv Hormonpflaster
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
US5951999A (en) * 1997-02-21 1999-09-14 Adhesives Research, Inc. Transdermal pressure sensitive adhesive drug delivery system
DE19728517C2 (de) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
DE19828273B4 (de) 2005-02-24
AR019715A1 (es) 2002-03-13
IL140434A0 (en) 2002-02-10
DE19828273A1 (de) 1999-12-30
CN1310616A (zh) 2001-08-29
AU4508699A (en) 2000-01-10
NZ509015A (en) 2004-01-30
WO1999066901A3 (de) 2000-03-23
DK1089719T3 (da) 2002-08-05
DE59901202D1 (de) 2002-05-16
JP2002518430A (ja) 2002-06-25
IL140434A (en) 2006-10-05
CA2335582A1 (en) 1999-12-29
AU768755B2 (en) 2004-01-08
HUP0102498A2 (hu) 2001-11-28
EP1089719A2 (de) 2001-04-11
KR20010053132A (ko) 2001-06-25
CZ20004798A3 (en) 2001-05-16
HUP0102498A3 (en) 2002-01-28
EP1089719B1 (de) 2002-04-10
CA2335582C (en) 2006-04-11
CN1148172C (zh) 2004-05-05
TR200003839T2 (tr) 2001-06-21
CZ300707B6 (cs) 2009-07-22
PL193080B1 (pl) 2007-01-31
ZA200007751B (en) 2001-07-18
TW533084B (en) 2003-05-21
PL345455A1 (en) 2001-12-17
KR100550888B1 (ko) 2006-02-10
ATE215819T1 (de) 2002-04-15
BR9912210A (pt) 2001-04-10
WO1999066901A2 (de) 1999-12-29
PT1089719E (pt) 2002-09-30
US6899894B1 (en) 2005-05-31

Similar Documents

Publication Publication Date Title
ES2177290T3 (es) Sistema de administracion transdermica con hormonas e inhibidores de cristalizacion.
ES2581574T3 (es) Sistema terapéutico transdérmico para la administración del principio activo buprenorfina
ATE352293T1 (de) Transdermales therapeutisches system mit fentanyl
HUP0401281A2 (hu) Gyógyszerek kontrollált beadására alkalmas mukoadhezív, erodálható, hatóanyag-bejuttató eszköz
PT1079813E (pt) Dispositivo transportador farmaceutico adequado para entrega de compostos farmaceuticos as superficies mucosas
DK0973497T3 (da) Farmaceutisk bæreanordning, egnet til udlevering af farmaceutiske forbindelser til slimhindeoverflade
PE20151147A1 (es) Sistema de liberacion transdermica
AR043248A1 (es) Sistema terapeutico transdermico estable a los rayos uv
US20060165764A1 (en) Tape preparation
ATE163854T1 (de) Dexpanthenol-haltiges pflaster zur transdermalen applikation von steroidhormonen
KR20150103077A (ko) 비스테로이드성 항염증제의 경피 전달을 위한 조성물 및 방법
CA2387143A1 (en) Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin
ES2253257T3 (es) Sistema de administracion transdermica para la transferencia de acido acetilsalicilico y/o acido salicilico.
MXPA01008785A (es) Composicion farmaceutica para el tratamiento de afecciones que cursan con inflamacion y/o dolor mediante la administracion transdermica de antiinflamatorios no esteroides incorporados en matrices polimericas acrilicas adhesivas.
AR028525A1 (es) Sistema terapeutico transdermal para la administracion de lerisetron
MXPA05008366A (es) Sistema terapeutico transdermico adecuado para la aplicacion de calor para promover la penetracion de sustancias activas y el uso del mismo.
AR027186A1 (es) Hojas de material plastico, particularmente para su utilizacion en un sistema terapeutico dermal o transdermal
DE59901355D1 (de) Transdermales therapeutisches system, enthaltend hormone und kristallisationsinhibitoren
ES2105334T3 (es) Sistema terapeutico percutaneo para la administracion de fisostigmina en la piel y el procedimiento para su obtencion.
DE20221161U1 (de) Transdermales therapeutisches System mit Fentanyl bzw. verwandten Substanzen
WO2004087099A3 (en) Methods and devices for holding a composition
ECSP003485A (es) Composiciones farmaceuticas